Johnson & Johnson
Stocks
CrowdStrike Holdings, Inc.
Stocks
Johnson & Johnson vs CrowdStrike Holdings, Inc.: Practical Daily-Use Investment Comparison
Last updated: June 4, 2026
Summary
Johnson & Johnson is a stable, dividend-paying healthcare giant with consistent revenue and low volatility, ideal for conservative daily investors. CrowdStrike Holdings, Inc. presents a high-growth, technology-focused profile with rapid revenue expansion but higher risk due to negative profit margins, suitable for aggressive, tech-savvy investors seeking innovation-driven returns.
Key Differences at a Glance
| Aspect | Johnson & Johnson | CrowdStrike Holdings, Inc. | Winner |
|---|---|---|---|
| Market Capitalization | USD 537.39 billion | USD 190.29 billion | Johnson & Johnson |
| Profitability | Profit margin of 21.8% | -3.4% | Johnson & Johnson |
| Dividend Yield | 2.4% | None | Johnson & Johnson |
| Beta (Volatility Measure) | 0.263 | 1.06 | Johnson & Johnson |
| Revenue Size | USD 96.36 billion | USD 4.81 billion | Johnson & Johnson |
Market Capitalization: Johnson & Johnson’s market cap exceeds $537 billion, indicating a highly stable and established company, ideal for conservative daily investors seeking reliable performance. CrowdStrike's market cap, while substantial at around $190 billion, reflects a high-growth tech stock with more volatility, suited for investors willing to accept higher risk.
Profitability: Johnson & Johnson maintains strong profitability with a profit margin of 21.8%, making it a dependable stock for daily income through dividends and stable returns. CrowdStrike, with a negative profit margin, indicates ongoing losses and higher risk, more appropriate for short-term or high-risk trading.
Dividend Yield: Johnson & Johnson offers a 2.4% dividend yield, providing immediate income for daily investors seeking regular cash flows. CrowdStrike does not pay dividends, making it less suitable for income-focused investors.
Beta (Volatility Measure): With a beta of 0.263, Johnson & Johnson shows very low volatility, appealing for daily investors prioritizing stability and minimal risk. CrowdStrike’s beta of 1.06 indicates higher market sensitivity, suitable for those seeking higher returns but willing to tolerate bigger price swings.
Revenue Size: Johnson & Johnson’s revenue dwarfs CrowdStrike’s, reflecting its established presence and consistent cash flow, ideal for daily investors prioritizing stability. CrowdStrike’s comparatively small revenue highlights its rapid growth potential but also higher operational risks.
Detailed Analysis
Johnson & Johnson (JNJ) is a stalwart in the healthcare industry, with a market capitalization of over $537 billion and annual revenues close to $96.4 billion. Its low beta of 0.263 indicates minimal market volatility, making it an attractive option for daily investors seeking stability and predictable returns. With a profit margin of 21.8%, JNJ consistently generates profits, enabling it to pay a dividend yield of 2.4%, providing a steady income stream for short-term investors. Its stock price fluctuated between $149.04 and $251.71 in the past year, reflecting moderate price stability.
In contrast, CrowdStrike Holdings, Inc. (CRWD) operates in the rapidly evolving cybersecurity software sector, with a market cap of approximately $190.3 billion. Despite its impressive growth potential, CrowdStrike reports a negative profit margin of -3.4%, indicating ongoing losses, which could be a concern for daily investors prioritizing income or stability. Its revenue of around $4.81 billion demonstrates strong revenue growth but less operational stability compared to JNJ. CrowdStrike’s stock price is significantly higher at $747.61, with a 52-week range from $342.72 to $785.66, showing higher volatility, especially given its beta of 1.06.
From a practical daily-use perspective, Johnson & Johnson’s stable dividend, low volatility, and large revenue base make it a dependable choice for income-focused investors or those seeking steady performance. In contrast, CrowdStrike appeals more to traders seeking higher growth potential, willing to accept higher risk and volatility, especially given its high forward P/E of over 121 and negative current profitability.
Overall, Johnson & Johnson provides a safer, income-generating investment suitable for conservative daily investors, while CrowdStrike offers dynamic growth prospects for risk-tolerant traders. The choice depends on whether stability or high-growth potential aligns with the investor’s daily investment goals.
Verdict
Johnson & Johnson is the clear winner for daily investors prioritizing stability, income, and low volatility, thanks to its substantial market cap, positive profit margins, and dividend yield. CrowdStrike, while attractive for high-growth, high-risk traders, is less suitable for conservative daily use due to its negative profit margin and higher volatility. For practical daily investment needs, JNJ’s consistent performance makes it the more reliable choice, especially for short-term income generation.
Who Should Choose What
Choose Johnson & Johnson if...
Best for conservative investors seeking steady income, low volatility, and reliable dividend payments. Ideal for those prioritizing safety and consistent performance in healthcare stocks.
Choose CrowdStrike Holdings, Inc. if...
Best for growth-focused traders and tech investors willing to tolerate higher risk, rapid revenue expansion, and the potential for significant capital gains in the cybersecurity sector.
Learn More
Related Comparisons
American Water Works Company, Inc. vs CrowdStrike Holdings, Inc.: A Industry and Use-Case Comparison
Berkshire Hathaway Inc. New vs Johnson & Johnson: A Performance-Driven Stock Comparison
Eli Lilly vs CrowdStrike: Which Stock Aligns Better with Your Investment Goals?
Meta Platforms, Inc. vs CrowdStrike Holdings, Inc.: A Beginner’s Guide to Stock Comparison
Johnson & Johnson vs Regency Centers Corporation: Performance Comparison for Investors